In patients, evidence accumulated for the pathophysiological importance of the MuSK CRD domain either by being linked to mutations in congenital myasthenic syndromes or by detection of autoantibodies in myasthenia gravis [64,65]. The gene discussed is MUSK; the disease is congenital myasthenic syndrome.